Mutant human interferons
US6299870A · kind A · utility
6Cited by
1References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 8, 1999 |
| Grant date | Oct 9, 2001 |
| Priority date | — |
| Expiry date | Feb 8, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new class of polypeptides is disclosed, along with a method for identifying and producing such polypeptides, having the characteristic of being unique to diseased states, particularly tumors and blood-borne malignancies. These new polypeptides are active and will be useful for therapeutic purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.